CompletedPHASE1, PHASE2NCT01745510

Enteral Administration of Docosahexaenoic Acid to Prevent Necrotizing Enterocolitis in Preterm Neonates

Studying Necrotizing enterocolitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Coordinación de Investigación en Salud, Mexico
Principal Investigator
Mariela Bernabe-Garcia, PhD
Instituto Mexicano del Seguro Social
Intervention
Docosahexaenoic acid (DHA)(dietary_supplement)
Enrollment
225 target
Eligibility
All sexes
Timeline
20122017

Study locations (1)

Collaborators

National Council of Science and Technology, Mexico

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01745510 on ClinicalTrials.gov

Other trials for Necrotizing enterocolitis

Additional recruiting or active studies for the same condition.

See all trials for Necrotizing enterocolitis

← Back to all trials